-+ 0.00%
-+ 0.00%
-+ 0.00%

Propanc Biopharma issues 3.5 million restricted shares to executives, directors, service providers

PUBT·08/21/2026 10:01:24
Listen to the news
Propanc Biopharma issues 3.5 million restricted shares to executives, directors, service providers
  • Propanc Biopharma board resolutions dated July 24, 2026 were executed via majority shareholder written consent.
  • Authorized issuance of 3.5 million restricted common shares to officers, directors, service providers under NASDAQ Listing Rules 5635(b) and 5635(c).
  • Largest allocation of 1 million restricted shares to CEO James Nathanielsz; multiple other recipients slated for 250,000 shares each.
  • Action becomes effective 20 days after the information statement is first mailed, scheduled on or about Aug. 20, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039522), on August 21, 2026, and is solely responsible for the information contained therein.